QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: Q14994
No. Gene UniProt ID Protein Name Pathway PDB
1 NR1I3 Q14994 Nuclear receptor subfamily 1 group I member 3 NA 1XV9; 1XVP


14 known interactions (drugs) of input target (NR1I3): Nuclear receptor subfamily 1 group I member 3
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Approved SmallMoleculeDrug DB00836 Loperamide Thumb
2 Experimental SmallMoleculeDrug DB01889 16,17-Androstene-3-Ol Thumb
3 Approved;
Withdrawn
SmallMoleculeDrug DB04824 Phenolphthalein Thumb
4 Approved;
Investigational
SmallMoleculeDrug DB04540 Cholesterol Thumb
5 Approved;
Experimental;
Investigational
SmallMoleculeDrug DB02709 Resveratrol Thumb
6 Approved;
Investigational
SmallMoleculeDrug DB01026 Ketoconazole Thumb
7 Approved;
Vet approved
SmallMoleculeDrug DB00366 Doxylamine Thumb
8 Approved SmallMoleculeDrug DB00737 Meclizine Thumb
9 Experimental SmallMoleculeDrug DB07557 (5BETA)-PREGNANE-3,20-DIONE Thumb
10 Approved SmallMoleculeDrug DB01620 Pheniramine Thumb
11 Approved;
Vet approved
SmallMoleculeDrug DB00257 Clotrimazole Thumb
12 Approved;
Investigational;
Nutraceutical
SmallMoleculeDrug DB01708 Prasterone Thumb
13 Approved;
Investigational
SmallMoleculeDrug DB08604 Triclosan Thumb
14 Withdrawn SmallMoleculeDrug DB07931 Hexestrol Thumb


20 predicted interactions (drugs) of input target (NR1I3): Nuclear receptor subfamily 1 group I member 3
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Experimental;
Investigational
SmallMoleculeDrug DB04216 Quercetin Thumb 39.1%
2 Approved;
Investigational;
Vet approved
SmallMoleculeDrug DB00312 Pentobarbital Thumb 38.1%
3 Approved;
Investigational
SmallMoleculeDrug DB00499 Flutamide Thumb 37.1%
4 Approved;
Investigational
SmallMoleculeDrug DB12010 Fostamatinib Thumb 36.6%
5 Approved SmallMoleculeDrug DB01173 Orphenadrine Thumb 36.5%
6 Approved;
Vet approved
SmallMoleculeDrug DB00396 Progesterone Thumb 35.7%
7 Approved SmallMoleculeDrug DB00675 Tamoxifen Thumb 33.7%
8 Approved;
Investigational;
Nutraceutical
SmallMoleculeDrug DB00755 Tretinoin Thumb 32.9%
9 Approved;
Investigational
SmallMoleculeDrug DB11994 Diacerein Thumb 32.5%
10 Approved SmallMoleculeDrug DB00421 Spironolactone Thumb 31.9%
11 Approved SmallMoleculeDrug DB03147 Flavin adenine dinucleotide Thumb 31.6%
12 Approved SmallMoleculeDrug DB00977 Ethinyl Estradiol Thumb 31.4%
13 Approved;
Investigational
SmallMoleculeDrug DB00255 Diethylstilbestrol Thumb 31.1%
14 Approved;
Withdrawn
SmallMoleculeDrug DB00431 Lindane Thumb 30.2%
15 Experimental SmallMoleculeDrug DB06732 beta-Naphthoflavone Thumb 29.5%
16 Approved;
Nutraceutical
SmallMoleculeDrug DB01373 Calcium Thumb 29.4%
17 Approved;
Investigational
SmallMoleculeDrug DB00555 Lamotrigine Thumb 28.5%
18 Approved;
Illicit
SmallMoleculeDrug DB01185 Fluoxymesterone Thumb 28.5%
19 Experimental SmallMoleculeDrug DB13951 Stanolone acetate Thumb 28.2%
20 Approved;
Investigational
SmallMoleculeDrug DB11064 Homosalate Thumb 27.9%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.